|
Match
|
Document |
Document Title |
|
|
7560446 |
Use of angiotensin II receptor antagonists for treating acute myocardial infarction
The invention relates to the use of an angiotensin II receptor antagonist or a pharmaceutically acceptable salt thereof for the manufacture of a medicament for the treatment of acute MI and for the...
|
|
|
7417037 |
Compositions and methods of treatment for inflammatory diseases
Inflammatory bowel diseases are represented by two idiopathic disorders, which include ulcerative colitis and Crohn's disease. Ulcerative colitis is restricted to the colon and involves uncertain...
|
|
|
7371760 |
***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***
Medicinal compositions containing aspirin
A combination of 2-acetoxy-5-(α-cyclopropylcarbonyl-2-fluorobenzyl)-4,5,6,7-
tetrahydrothieno[3,2-c]pyridine or a pharmaceutically acceptable salt thereof, and aspirin, which possess excellent...
|
|
|
7368469 |
Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
Use of an inhibitor of the renin-angiotensin system or a pharmaceutically acceptable derivative thereof, optionally together with another antihypertensive, a cholesterol lowering agent, a diuretic...
|
|
|
7338971 |
Treatment of inflammatory, cancer, and thrombosis disorders
This invention provides for the treatment of inflammatory, cancer and thrombotic disorders through the administration, in combination, of a COX2 inhibitor, low dose aspirin, and antioxidant...
|
|
|
7323452 |
Method for the accelerated in vivo removal of ethanol
A method for accelerating the process of removing ethanol from the blood through the use of certain additives that accelerate the metabolic oxidation of ethanol, and others which in addition act as...
|
|
|
7202229 |
Aspirin formulation for cardiovascular health
The invention relates generally to an aspirin formulation which may comprise additional vitamins, minerals, herbs and supplements and methods for using the same for maintaining cardiovascular...
|
|
|
7098195 |
Fluorinated glucosamine analogs useful for modulating post-translational glycosylations on cells
The present invention provides compositions and methods for inhibiting cell migration, e.g., lymphocytes and inflammation. The invention also provides an improved process for preparing fluorinated...
|
|
|
7094431 |
Method of healing skin wounds in mammals and a composition therefor
This invention pertains to therapeutic antibacterial/antifungal-wound healing compositions comprising a therapeutically effective amount of antibacterial agents and/or antifungal agents and/or...
|
|
|
7029706 |
Composition for the treatment of cutaneous mycosis
The inventions relates to the use of silica in the formulation of antifungal composition for the treatment of cutaneous mycoses, and method to manufacture an antifungal powder with boric acid and...
|
|
|
7018990 |
Combination of a factor Xa inhibitor and clopidogrel
The present application describes methods of using a combination of...
|
|
|
6964782 |
Stable hydrogen peroxide compositions, products and methods of use
Disclosed are several preferred embodiments of hydrogen peroxide which are packaged with ease of use and extended shelf-life in mind. The embodiments include foam, mist, gel, and disposable...
|
|
|
6919325 |
Pharmaceutical compositions containing tiotropium salts and low-solubility salmeterol salts
Pharmaceutical compositions and kits comprising:
(a) a tiotropium salt; and (b) a salmeterol salt having a solubility in water of 0.1 mg/mL or less,
processes for preparing them, and their...
|
|
|
6855734 |
Glycine betaine and its use
Pharmaceutical uses of glycine betaine, such as for the treatment of thromboses not induced by hyperhomocystenemia or homocystinuria, of blood disorders, such as blood coagulation, thrombi formation.
|
|
|
6846837 |
Topical administration of basic antifungal compositions to treat fungal infections of the nails
Methods and topical pharmaceutical formulations are provided for the treatment of nail fungus (onychomycosis). The invention involves a pharmacologically active antifungal agent, plus a...
|
|
|
6833362 |
Method and composition for the accelerated in vivo removal of ethanol
A composition for accelerating the disposal of ethanol from bodily fluid. Certain additives can accelerate the metabolic oxidation of ethanol, and others in addition act as catalysts or...
|
|
|
6743770 |
Nutritional supplement for the management of stress
A nutritional supplement to be incorporated into the diet of an individual under stress (e.g., chronic stress) is described, comprising a low-glycemic-index carbohydrate, alpha lactalbumin-enriched...
|
|
|
6730329 |
Zinc containing compositions for anti-viral use
One aspect of the invention relates to anti-viral composition containing at least one zinc compound and at least one phenolic antioxidant (and optionally other ingredients such as at least one...
|
|
|
6511968 |
Combination therapy for treating, preventing, or reducing the risks associated with acute coronary ischemic syndrome and related conditions
The invention provides a method for treating, preventing, or reducing the risk of developing a condition selected from the group consisting of acute coronary ischemic syndrome, thrombosis,...
|
|
|
6503916 |
Treatment of ischemic brain injury
A composition and method adapted for the treatment of ischemic brain injury is disclosed, which includes applying hypothermic conditions to a subject within 5 hours after onset of brain injury and...
|
|
|
6503915 |
Composition and method for treatment of cerebral ischemia
A composition and method for the treatment of cerebral ischemia is disclosed, the composition is a mixture of caffeine and alcohol and is used to treat cerebral ischemia by administering to a...
|
|
|
6403571 |
Combination therapy for reducing the risks associated with cardiovascular disease
The instant invention involves a combination therapy and pharmaceutical compositions comprised of a therapeutically effective amount of a cholesterol reducing agent such as an HMG-CoA reductase...
|
|
|
6326364 |
Use of 5-aminosalicylates as antimicrobial agents
A method of inhibiting the growth of a bacterial species in a human or non-human vertebrate employs the antimicrobial (i.e., antibiotic) properties of 5-aminosalicylates. These antimicrobial...
|
|
|
6306842 |
Protected forms of a combination of pharmacologically active agents and uses therefor
In accordance with the present invention, there are provided conjugates of a combination of pharmacologically active agents (e.g., NSAIDs and selective COX-2 inhibitors). Invention conjugates...
|
|
|
6232341 |
Topical pharmaceutical compositions for healing wounds
The present invention provides a topical pharmaceutical composition for wound healing, which comprises (a) borneol and (b) bismuth subgallate in effective amounts. The topical pharmaceutical...
|
|
|
6127352 |
Pharmaceutical compositions with analgesics containing codeine
Compositions for the relief of pain containing acetyl salicylic acid or acetaminophen as a peripherally acting analgesic and codeine as a centrally acting agent.
|
|
|
6074634 |
Feeding attractant and stimulant for adult control of noctuid and/or other lepidopteran species
The present invention provides an composition for attracting noctuid and/or other lepidopteran species. Liquid and solid formulations are provided, along with methods for their use, for controlling...
|
|
|
6030977 |
Fungicide salts
Combining pyrimethanil with an organic acid having a volatility of less than 2 Pa at 20° C. results in a product which has valuable physical and biological properties.
|
|
|
5977176 |
Compositions for the treatment of warts and herpes
Compositions comprising propolis, propolis and salicylic acid, or propolis and either a corticorsteroid such as hydrocortisone or a halogenated corticosteroid with or without salicylic acid, are...
|
|
|
5976498 |
Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands
The present invention is directed to complexes represented by the formula: ##STR1## wherein R, R', R 1 , R' 1 , R 2 , R' 2 , R 3 , R' 3 , R 4 , R' 4 , R 5 , R' 5 , R 6 , R' 6 , R 7 , R' 7 , R 8 ,...
|
|
|
5948443 |
Acetylsalicylic acid and micronutrient supplementation for nutritional losses and coronary heart disease
The present invention pertains generally to the field of Public Health, including the prevention and treatment of coronary heart disease which is currently the first cause of death in the American...
|
|
|
5939455 |
Therapeutic augmentation of oxyalkylene diesters and butyric acid derivatives
This invention provides a method of augmenting the therapeutic activity of an oxyalkylene-containing compound, butyric acid, a butyric acid salt or butyric acid derivative by administering an...
|
|
|
5919776 |
Substituted aminoquinolines as modulators of chemokine receptor activity
The present invention is directed to aminoquinolines of Formula I: ##STR1## (wherein R 1 , R 2 , R 3 , and R 4 are defined herein) which are useful as modulators of chemokine receptor activity. In...
|
|
|
5902805 |
Method for treatment of acne and/or the effects of ageing using HMG-coenzyme A-reductase inhibitor and compositions for performing the same
A method for the treatment of acne and/or the effects of ageing, by administering, to a subject in need thereof, a composition containing an effective amount of at least one HMG-Coenzyme...
|
|
|
5900416 |
Aqueous caffeine dosage forms
Aqueous caffeine solutions containing a co-solubilizing agent selected from niacinamide, nicotinic acid and mixtures thereof present at a level up to the maximum concentration soluble in water and...
|
|
|
5889026 |
4-hydroxy-piperodine derivatives
The present invention relates to compounds of the formula ##STR1## wherein x is --O--, --NH--, --CH 2 --, --CH, --CO 2 --, --CONH--, --CON(lower alkyl)--, --S-- and --SO 2 --; R 1 -R 4 ...
|
|
|
5827832 |
Method of protecting brain tissue from cerebral infarction subsequent to ischemia
The invention is directed to a method of reducing the extent of infarction, particularly cerebral infarction subsequent to cerebral ischemia, by the administration of citicoline shortly after an...
|
|
|
5811426 |
Urea and thiourea derivatives of azolones
The invention is concerned with the compounds having the formula ##STR1## the pharmaceutically acceptable addition salts and the stereochemically isomeric forms thereof, wherein X is O or S; Y is...
|
|
|
5776919 |
Potentiators of antimicrobial activity
The present invention provides antimicrobial compositions, especially compositions comprising an antimicrobial (microbiocidal or microbiostatic) compound and a potentiator of antimicrobial...
|
|
|
5753637 |
Method of treating acne conditions
The acne treatment method of the present invention includes applying to skin a composition including an effective amount of acne treatment medication selected from the group consisting of benzoyl...
|
|
|
5750559 |
Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non-steroidal anti-inflammatory drugs
The antireactive-antiasthmatic effect of inhaled loop diuretics is potentiated by the use of a combination of a loop diuretic and a non-steroidal anti-inflammatory drug as an inhalant for combating...
|
|
|
5700784 |
External preparation for skin
An external preparation for the skin comprising at least one of the glycosides or hydroxysaliyclic acid and/or the glycosides of aliphatic esters of hydroxysalicylic acid represented by the...
|
|
|
5656620 |
Method for treating pain
Treatment and prophylaxis of pain involves administration of vitamin E combined with salicylic acid in a pharmaceutically acceptable carrier or adjuvant.
|
|
|
5612054 |
Pharmaceutical compositions for treating gastrointestinal distress
This invention relates to a pharmaceutical composition for treating gastrointestinal distress comprising an effective amount of an antidiarrheal composition, e.g. loperamide, and an antiflatulent...
|
|
|
5556855 |
N-heterocyclic substituted salicylic acids
A compound of the formula Het--NR--SO 2 --Ph 2 --A--Ph 1 (COOH)(OH) and tautomic form, salts, solvates, C 1 -6 alkyl esters and pharmaceutical compositions of the compound. Ph 1 and Ph 2 are...
|
|
|
5543405 |
Composition and method for weight reduction and long term management of obesity
A weight reduction composition comprises a sympathomimetic agent and a mineral cation salt or chelate capable of enhancing carbohydrate metabolism, protein or fatty acid synthesis, retarding...
|
|
|
5489579 |
Potentation of NMDA antagonists
The present invention is directed to a method for poteniating the therapeutic effects of selected NMDA antagonists.
|
|
|
5480651 |
Composition and method for treating nicotine craving in smoking cessation
A method for relieving craving in a nicotine-habituated patient and a composition for treating the patient is provided. The composition administered has a non-specific acetylcholine agonist and a...
|
|
|
5466436 |
Medicaments for treating inflammatory conditions or for analgesia
The use is described of both (i) ranitidine bismuth citrate and (ii) a non-steroidal anti-inflammatory drug in treating or preventing inflammatory conditions and for analgesia. Pharmaceutical...
|
|
|
5451579 |
1-β-methyl-carbapenem, compositions containing same and methods of use
A carbapenem antibiotic of the formula I ##STR1## is disclosed. The variable X .crclbar . represents a counterion. Pharmaceutical compositions and methods of use are also disclosed.
|